U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and ...
Billions of clinical insights—once buried in an unusable format—may now be used to train large language models and inform clinical research studies.